Field trial oral cholera vaccines Bangladesh serum vibriocidal antitoxic antibodies markers risk cholera relationship serum vibriocidal VC IgG anti-cholera toxin CT risk cholera first year follow-up recipients oral doses subunit BS -whole-cell vaccine whole-cell vaccine Escherichia strain placebo Bangladesh Acute sera cholera patients sera contemporaneous community controls VC titer average reduction cholera risk groups contrast groups BS anti-CT titers cholera markers cholera risk vaccine protective efficacy cholera antibody titers vaccine efficacy serum VC anti-CT antibodies poor markers longitudinal pattern vaccine efficacy 